Related Experiment Video
Updated: Sep 13, 2025
Author Spotlight: Unlocking Insights into the Immune Cell Landscape of Tumors
Published on: August 18, 2023
Multiplex imaging analysis of the tumor immune microenvironment for guiding precision immunotherapy
Feng Liu1,2,3, Guiqing Li2,3, Yi Zheng2,3
1Faculty of Medical Images, Shandong Second Medical University, Weifang, Shandong, China.
Insights
Advanced multiplex imaging reveals spatial immune signatures in the tumor microenvironment (TIME). These findings predict immunotherapy response and personalize cancer treatment, improving patient outcomes.
Area of Science:
- Oncology
- Immunology
- Biotechnology
Background:
- The tumor immune microenvironment (TIME) is crucial for cancer progression and treatment response.
- Understanding spatial cellular interactions within the TIME is key to developing effective therapies.
Purpose of the Study:
- To review cutting-edge multiplex imaging technologies for analyzing the TIME.
- To highlight their role in identifying spatial immune signatures predictive of immunotherapy response.
- To discuss clinical applications and future directions in precision immunotherapy.
Main Methods:
- Review of multiplex imaging techniques: Imaging Mass Cytometry (IMC), Multiplexed Ion Beam Imaging (MIBI), Cyclic Immunofluorescence (CycIF), and Digital Spatial Profiling (DSP).
- Analysis of clinical applications across Non-Small Cell Lung Cancer (NSCLC), melanoma, breast cancer, colorectal cancer, and hepatocellular carcinoma.
- Integration of spatial data with immunotherapy response and patient stratification.
Main Results:
- Multiplex imaging provides nanometer-scale resolution of cellular interactions within the TIME.
- Spatial immune profiles, particularly CD8+ T cell density and tumor cell colocalization, correlate with improved immunotherapy response and survival.
- These profiles enhance patient stratification and treatment personalization across various cancers.
Conclusions:
- Multiplex imaging technologies are powerful tools for dissecting the TIME and predicting immunotherapy outcomes.
- Spatially resolved immune signatures offer significant potential for personalized cancer medicine.
- Future advancements in imaging and integration with other spatial omics will further enhance clinical utility.
Abstract:
Cutting-edge multiplex imaging technologies have significantly advanced our understanding of the tumor immune microenvironment (TIME), delivering nanometer-scale spatial resolution that illuminates previously inaccessible cellular interactions and organizational patterns. This mini-review discusses the latest multiplex imaging methods, including Imaging Mass Cytometry (IMC), Multiplexed Ion Beam Imaging (MIBI), Cyclic Immunofluorescence (CycIF), and Digital Spatial Profiling (DSP), emphasizing their roles in identifying spatial immune signatures predictive of immunotherapy responses. Clinical applications across various cancers-such as NSCLC, melanoma, breast cancer, colorectal cancer, and hepatocellular carcinoma-highlight how spatially resolved immune profiles can enhance patient stratification and treatment personalization. Notably, increased CD8+ T cell density and spatial colocalization with tumor cells have been broadly correlated with improved immunotherapy response and survival across multiple cancer types. Despite current technical and analytical challenges, ongoing technological advancements and integration with emerging methods like spatial transcriptomics and super-resolution imaging promise broader clinical utility, ultimately improving patient outcomes in precision immunotherapy.
More Related Videos
09:32Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
Published on: February 8, 2018
08:18Multiplexed Barcoding Image Analysis for Immunoprofiling and Spatial Mapping Characterization in the Single-Cell Analysis of Paraffin Tissue Samples
Published on: April 7, 2023
